G Franci, L Palomba, A Falanga, C Zannella… - The microbiology of …, 2016 - Elsevier
The viral family Orthomyxoviridae comprises five genera, but only two are of medical relevance in humans, namely: influenza A and B viruses. Influenza A viruses are further …
With coronavirus disease 2019 (COVID-19), it is now clear that the preparedness of the healthcare system for the levels of morbidity and mortality that could occur with a serious …
N Uno, TM Ross - Scientific Reports, 2024 - nature.com
Each year, new influenza virus vaccine formulations are generated to keep up with continuously circulating and mutating viral variants. A next-generation influenza virus …
The development of safe and effective vaccines in a record time after the emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a remarkable …
CV Forst - Future Virology, 2012 - Taylor & Francis
Seasonal flu affects 5–20% of the human population each year. Although mortality rates are typically< 0.1% and the pandemic 2009 H1N1 influenza strain has been well contained by …
K Asha, C Meseko, B Kumar - Frontiers in Molecular Biosciences, 2023 - frontiersin.org
Influenza is a highly contagious respiratory disease caused by influenza A, B, and C viruses in humans and accounts for 30% of all respiratory viral infections. These viruses (influenza A …
ACY Hsu - Frontiers in Immunology, 2018 - frontiersin.org
Influenza is a contagion that has plagued mankind for many decades, and continues to pose concerns every year, with millions of infections globally. The frequent mutations and …
Influenza virus infection is an ongoing health and economic burden causing epidemics with pandemic potential, affecting 5–30% of the global population annually, and is responsible …
Vaccination is still the most efficient way to prevent an infection with influenza viruses. Nevertheless, existing commercial vaccines face serious limitations such as availability …